AU2021224852A1 - Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration - Google Patents

Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration Download PDF

Info

Publication number
AU2021224852A1
AU2021224852A1 AU2021224852A AU2021224852A AU2021224852A1 AU 2021224852 A1 AU2021224852 A1 AU 2021224852A1 AU 2021224852 A AU2021224852 A AU 2021224852A AU 2021224852 A AU2021224852 A AU 2021224852A AU 2021224852 A1 AU2021224852 A1 AU 2021224852A1
Authority
AU
Australia
Prior art keywords
acetate
oligonucleotide
sodium
buffer solution
retentate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021224852A
Other languages
English (en)
Inventor
Geetha Govindan
Robert S. Gronke
Jonas P. IMMEL-BROWN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen MA Inc filed Critical Biogen MA Inc
Publication of AU2021224852A1 publication Critical patent/AU2021224852A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/313—Phosphorodithioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AU2021224852A 2020-02-21 2021-02-19 Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration Pending AU2021224852A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062979687P 2020-02-21 2020-02-21
US62/979,687 2020-02-21
PCT/US2021/018856 WO2021168306A1 (en) 2020-02-21 2021-02-19 Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration

Publications (1)

Publication Number Publication Date
AU2021224852A1 true AU2021224852A1 (en) 2022-10-13

Family

ID=74870921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021224852A Pending AU2021224852A1 (en) 2020-02-21 2021-02-19 Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration

Country Status (11)

Country Link
US (1) US20230116671A1 (ja)
EP (1) EP4107261A1 (ja)
JP (1) JP2023515485A (ja)
KR (1) KR20220156843A (ja)
CN (1) CN115997013A (ja)
AU (1) AU2021224852A1 (ja)
BR (1) BR112022016598A2 (ja)
CA (1) CA3168716A1 (ja)
IL (1) IL295757A (ja)
MX (1) MX2022010310A (ja)
WO (1) WO2021168306A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4329923A1 (en) * 2021-04-30 2024-03-06 Hydranautics Concentration and diafiltration of oligonucleotides
WO2023164631A1 (en) * 2022-02-25 2023-08-31 Amgen Inc. Methods of preparing high concentration liquid drug substances

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074333B2 (en) * 2001-01-19 2006-07-11 Millipore Corporation Recovery of linear nucleic acids by salt dilution and/or reduced pressure prior to continuous pressure differential ultrafiltration
GB201012418D0 (en) * 2010-07-23 2010-09-08 Santaris Pharma As Process
BR112015022660A2 (pt) * 2013-03-14 2017-10-31 Shire Human Genetic Therapies métodos para a purificação de rna mensageiro
ES2923018T3 (es) * 2013-03-15 2022-09-22 Glaxosmithkline Biologicals Sa Métodos de purificación de ARN
CN107873055B (zh) * 2015-05-29 2021-09-17 库瑞瓦格房地产有限公司 包括至少一个切向流过滤步骤的产生和纯化rna的方法
EP3658155A4 (en) * 2017-07-28 2021-06-30 Nogra Pharma Limited PROCESS FOR THE PREPARATION OF OLIGONUCLEOTIDIC COMPOUNDS

Also Published As

Publication number Publication date
EP4107261A1 (en) 2022-12-28
MX2022010310A (es) 2023-01-24
WO2021168306A1 (en) 2021-08-26
BR112022016598A2 (pt) 2022-11-08
CA3168716A1 (en) 2021-08-26
CN115997013A (zh) 2023-04-21
IL295757A (en) 2022-10-01
US20230116671A1 (en) 2023-04-13
KR20220156843A (ko) 2022-11-28
JP2023515485A (ja) 2023-04-13

Similar Documents

Publication Publication Date Title
US20230116671A1 (en) Methods of preparing oligonucleotide compositions using ultrafiltration/diafiltration
DE60128945T2 (de) Verfahren zur abtrennung von extrachromosomaler dns aus einer zellsuspension
BRPI0809212A2 (pt) Processo de purificação abreviado para a produção de polissacarídeos capsulares de streptococcus pneumoniae
EP2723760B1 (de) Verfahren zur abtrennung von biopolymer-aggregaten und viren aus einem fluid
AU2017313268B2 (en) Process for the preparation of highly concentrated liquid formulations containing biomolecules
JP2022521161A (ja) タンジェントフローろ過によるｍＲＮＡ精製
EP3185887B1 (en) Method for preparing crystalline insulin or insulin analog compositions
EP3077414B1 (en) Method for preparing crystalline insulin
US20230174966A1 (en) Rna purification method
CA2178369C (en) Process for the purification and crystallisation of iopamidol
JP2003306497A (ja) 巨大分子結晶の製造方法及びそれに用いる製造装置
CN109431996B (zh) 一种含米诺地尔的外用剂组合物及其制备方法
EP1062237B1 (de) Metallhaltige ribonukleotidpolypeptide
EP3153522A1 (en) Process for the purification of erythropoietin and darbepoetin alfa
JP2017531643A (ja) ヘモペキシンでの治療のための組成物および方法
RU2453331C1 (ru) Способ получения высокоочищенного кристаллического инсулина любого происхождения
CN104958255A (zh) 一种氟马西尼注射液及其制备方法
CN110256533A (zh) 一种高纯度的多臂抗癌偶联物
TW202323269A (zh) 方法
CN116270454A (zh) 盐酸丙卡特罗口服溶液及其制备方法
DE102022121980A1 (de) Neue Toxin-Bindemittel für die Hämodialyse
US20170101437A1 (en) Process for purification of darbepoetin alfa
CN116251059A (zh) 一种地高辛注射液的制备方法
JP2006034113A (ja) ホタテのウロのエキスの調製方法
CN110934836A (zh) 一种托吡司特滴丸及其制备方法